Bibliographie (2530)
M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.
mercredi, 07 juillet 2021 11:10 Écrit par Zouhair SouissiSystematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research – Transfusion Medicine
The post M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19. appeared first on Links Medicus.
WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access – “These are the first drugs found to be effective against COVID-19 since corticosteroids were recommended by WHO in Sep
mercredi, 07 juillet 2021 11:10 Écrit par Zouhair SouissiWHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access – World Health Organization Commentary on Twitter (thread – click for more) ? treatment recommendation from WHO:WHO recommends life-saving interleukin-6 receptor blockers to treat #COVID19 and urges producers to join efforts to rapidly increase access. ?https://t.co/h4IcZad2VA […]
The post WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access – “These are the first drugs found to be effective against COVID-19 since corticosteroids were recommended by WHO in September 2020”. appeared first on Links Medicus.
M-A: Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 – “The 4% absolute risk reduction in mortality from 25% to 21% with IL-6 inhibition added to glucocorticoids may not translate to patients w
mercredi, 07 juillet 2021 11:10 Écrit par Zouhair SouissiAssociation Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis – JAMA Editorial: IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How? – JAMA Commentaries: Interleukin-6 antagonists improve outcomes in hospitalised COVID-19 patients – King’s College London AND WHO advises 2 monoclonal antibodies for severe COVID […]
The post M-A: Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 – “The 4% absolute risk reduction in mortality from 25% to 21% with IL-6 inhibition added to glucocorticoids may not translate to patients with a lower baseline mortality risk and likely do not justify the additional expense and risk for toxicities for patients hospitalized with modest oxygen requirements and a stable clinical course (from editorial)”. appeared first on Links Medicus.
A living WHO guideline on drugs for covid-19 – interleukin-6 receptor blockers are now recommended for patients with severe or critical covid-19.
mercredi, 07 juillet 2021 11:10 Écrit par Zouhair SouissiA living WHO guideline on drugs for covid-19 – The BMJ Commentary on Twitter The latest version of this @WHO living guidance provides a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19. Read the updated WHO guideline on drugs for #COVID19 https://t.co/FUb9yzFRwo — The BMJ […]
The post A living WHO guideline on drugs for covid-19 – interleukin-6 receptor blockers are now recommended for patients with severe or critical covid-19. appeared first on Links Medicus.
RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19.
mardi, 06 juillet 2021 19:00 Écrit par Zouhair SouissiIvermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial – BMC Infectious Diseases Commentary: Ivermectin: balance of evidence shows no significant benefit against Covid-19 – MSN News Related: Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, […]
The post RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19. appeared first on Links Medicus.
Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.
mardi, 06 juillet 2021 19:00 Écrit par Zouhair SouissiChoosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians – Nature Medicine
The post Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians. appeared first on Links Medicus.
Joint COVAX Statement on the Equal Recognition of Vaccines – COVAX urges all government authorities to recognize as fully vaccinated all people who have received COVID-19 vaccines that have been deemed safe and effective by WHO.
lundi, 05 juillet 2021 06:19 Écrit par Zouhair SouissiJoint COVAX Statement on the Equal Recognition of Vaccines – World Health Organization Commentary on Twitter (thread – click for more) #COVAX urges all government authorities to recognize as fully vaccinated all who have received #COVID19 vaccines approved by WHO or one of 11 approved Stringent Regulatory Authorities, when making decisions on who is […]
The post Joint COVAX Statement on the Equal Recognition of Vaccines – COVAX urges all government authorities to recognize as fully vaccinated all people who have received COVID-19 vaccines that have been deemed safe and effective by WHO. appeared first on Links Medicus.
CDC Report: Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020–March 2021.
lundi, 05 juillet 2021 06:19 Écrit par Zouhair SouissiUnderlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021 – Centers for Disease Control and Prevention Commentary on Twitter A new report finds that obesity, diabetes with complication, and the presence of multiple chronic conditions were the strongest chronic risk factors for death from #COVID19 among hospitalized adults. […]
The post CDC Report: Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020–March 2021. appeared first on Links Medicus.
RCT: Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19 – no difference in intubation rates compared to standard care.
lundi, 05 juillet 2021 04:35 Écrit par Zouhair SouissiAwake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial – Critical Care Related: Feasibility and Physiological Effects of Prone Positioning in Non-intubated Patients with Acute Respiratory Failure due to COVID-19
The post RCT: Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19 – no difference in intubation rates compared to standard care. appeared first on Links Medicus.
Seminar | Acute respiratory distress syndrome.
lundi, 05 juillet 2021 04:35 Écrit par Zouhair SouissiAcute respiratory distress syndrome – The Lancet
The post Seminar | Acute respiratory distress syndrome. appeared first on Links Medicus.
